N@N

SinoFresh Nasal Spray Achieves Positive Results Against H1N1 (Swine Flu) Virus in Initial Pilot Animal Study

_{//health-fitness.news-articles.net/content/2009/ .. ine-flu-virus-in-initial-pilot-animal-study.html}
^{Published in Health and Fitness on Monday, November 23rd 2009 at 11:29 GMT by Market Wire}  

VENICE, FL--(Marketwire - November 23, 2009) - SinoFresh HealthCare, Inc. (PINKSHEETS: [ SFSH ]) announced today the successful results of its initial pilot animal study testing the efficacy of the SinoFresh Nasal Spray product when used on animals infected with the H1N1 ("swine flu") virus. The study data suggests that treatment with SinoFresh allowed the infected animals to recover more rapidly from H1N1 infection than did untreated animals. In addition, pre-treatment with SinoFresh Nasal Spray decreased the severity and/or incidence of infection.

Dr. Michael Stampar, D.O., Senior Medical Advisor to SinoFresh HealthCare Products, stated, "We are very encouraged by this initial study report and will continue to develop data to support our belief that SinoFresh Nasal Spray, a broad-based antiseptic solution, is an important component in protecting the health of patients that are exposed to the H1N1 ('swine flu') virus."

The study, which was conducted by SRS International Corp. of Falls Church, VA, was conducted over 14 days and was designed to evaluate the severity of infection from H1N1 ("swine flu") virus in the Cotton Rat animal model, a well accepted model for studying human nasal and respiratory tract infection by viruses and other microbial pathogens. In this study, the test animals were inoculated with H1N1 and then received SinoFresh Nasal Spray in the nose three times daily for 14 days.

The study evaluated the product's likelihood of efficacy in both prevention and treatment. One group of animals was treated with SinoFresh Nasal Spray prior to inoculation with H1N1 and a second group was treated starting 15 minutes after inoculation with H1N1 while the remaining "control group" received no treatment during the overall 14-day study period.

The Company has now also initiated a study to evaluate the product's ability to reduce or eliminate viral shedding which is the main method of transmission of the H1N1 flu virus. The active phase of the additional study has been completed and is in the laboratory for evaluation. Results are expected in the next few weeks.

About SinoFresh™ HealthCare, Inc.

SinoFresh™ HealthCare, Inc. is a developer and marketer of therapies to treat inflammatory and infectious diseases of the upper respiratory system. The Company is researching broad-spectrum antiseptic approaches to reducing viral, bacterial and fungal organisms suspected of causing pathogenesis of the mouth nose and throat. The Company holds certain patents and patent applications on its innovative pharmaceutical technology and relies upon a panel of medical experts and management team experienced in the bio-pharmaceutical industry.

The Company's product, SinoFresh™ Nasal & Sinus Care, is the only over-the-counter antiseptic nasal spray that kills bacteria and fungi and viral pathogens in the throat and nasal passages. The Company is also researching how antiseptic cleansing may aid in alleviating sinus distress, a problem that affects many Americans annually. More information is available at [ www.sinofresh.com ].

*SinoFresh™ is a trademark of SinoFresh HealthCare, Inc.

For further information company can be contacted at 888-460-4774, or on the web at [ www.sinofreshproducts.com ], or by email at [ customerservice@sinofreshproducts.com ].

Except for the historical information contained herein, this press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any forward-looking statements speak only as of the date on which such statements are made and involve risks and uncertainties detailed in the Company's filings with the Securities and Exchange commission, including risks summarized in the company's annual Report of form 10-KSB for its fiscal year ended December 31, 2006 (file No.49764). The Company's actual results could differ materially from such forward-looking statements. The Company undertakes no obligation to update any forward-looking statement or statements to reflect new events or circumstances or future developments.